Description
Retatrutide is an investigational synthetic peptide belonging to the triple-receptor agonist class. It is characterised by activity at three metabolic receptors: GLP-1, GIP and glucagon.
LIFE supplies Retatrutide 10 mg as a high-purity, lyophilised peptide for laboratory and analytical research. Each batch is accompanied by a Certificate of Analysis (COA), with additional independent verification available for selected batches.
Product characteristics
| Specification | Details |
| Product | Retatrutide |
| Quantity | 10 mg per vial |
| Form | Lyophilised powder |
| Purity | ≥99% (HPLC) |
| Molecular formula: | C221H342N46O68 |
| Molecular weight | 4731.33 g/mol |
| Research category | Triple GLP-1/GIP/glucagon receptor agonist |
| Storage | Refrigerated at 2–8°C |
| Intended application | Laboratory and analytical research |
Quality control
Current batch: RT10-260410
- Internal HPLC purity: 99.17%
- Independent verification: 99.57%
- Testing laboratory: Janoshik Analytical
View third-party verification.
Further information
For a comparison of related compounds and their receptor profiles, see our Retatrutide vs Tirzepatide research comparison.
For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.
Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.
